학술논문

KEYNOTE-991: pembrolizumab plus enzalutamide and androgen deprivation for metastatic hormone-sensitive prostate cancer
Document Type
Journal
Source
FUTURE ONCOLOGY; JAN 27 2023, 9p.
Subject
Language
English
ISSN
17448301